India opened an anti-dumping investigation on Sept. 30, 2026 into clavulanic acid and its amine salt from China and the European Union.<\/p>\n
India’s Directorate General of Trade Remedies (DGTR) opened an anti-dumping investigation on Sept. 30, 2026 into imports of clavulanic acid and its amine salt from China and the European Union1<\/a><\/sup>.<\/p>\n The case was filed by Kinvan Private Limited, which says it is the only Indian maker of the product covered by the case2<\/a><\/sup>. The investigation could lead to an extra import duty on the goods from both origins.<\/p>\n In short, India is checking whether Chinese and European suppliers sell a key antibiotic ingredient in India below its fair price. No duty applies yet, but shipments from China and the EU could face one if the case ends with a duty recommendation.<\/p>\n An anti-dumping duty is an extra import tax on goods sold abroad below their normal price. DGTR, the trade remedies office of India’s commerce ministry, runs these cases and recommends duties2<\/a><\/sup>. The government then decides whether to apply them.<\/p>\n The notice was printed in the Gazette of India, Extraordinary, Part I, Section 1, No. 303, dated Sept. 30, 20261<\/a><\/sup>. Its file number is F. No. 6\/51\/2026-DGTR and its case number on DGTR’s online filing system is AD\/OI\/054\/2026<\/strong>1<\/a><\/sup>.<\/p>\n Kinvan has asked for anti-dumping duty on imports<\/strong> of the goods from China and the EU2<\/a><\/sup>. It says the low-priced imports are holding back the start of its new business in India.<\/p>\n The case covers clavulanic acid, also called potassium clavulanate<\/strong>, and its intermediate amine salt2<\/a><\/sup>. Clavulanic acid is an active pharmaceutical ingredient, the part of a medicine that does the work. It helps antibiotics work against bacteria that resist them2<\/a><\/sup>.<\/p>\nWhat is the clavulanic acid investigation about?<\/h2>\n
Which antibiotic ingredients are covered?<\/h2>\n
What the clavulanic acid case covers<\/h4>\n